Jonathan Woodson, MD in East Boston, MA - Surgery

Jonathan Woodson, MD is a Surgery - Vascular Surgery physician based in East Boston, Massachusetts. Jonathan Woodson is licensed to practice in Massachusetts (license number 48097) and his current practice location is 10 Gove St, East Boston, Massachusetts. He can be reached at his office (for appointments etc.) via phone at (617) 569-5800.

NPI number for Jonathan Woodson is 1861431975 and his current mailing address is 10 Gove St, East Boston, Massachusetts. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1861431975.

Contact Information

	Jonathan Woodson, MD
	10 Gove St, East Boston, MA 02128-1920
	(617) 569-5800
	(617) 568-4780

Physician's Profile

Full Name	Jonathan Woodson
Gender	Male
Speciality	Surgery - Vascular Surgery
Location	10 Gove St, East Boston, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1861431975
Provider Enumeration Date: 06/05/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Jonathan Woodson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1861431975	NPI	-	NPPES
3036251	Medicaid	MA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2086S0129X	Surgery - Vascular Surgery	48097 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jonathan Woodson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jonathan Woodson, MD 10 Gove St, East Boston, MA 02128-1920 Ph: (617) 569-5800	Jonathan Woodson, MD 10 Gove St, East Boston, MA 02128-1920 Ph: (617) 569-5800

News Archive

Trigger warnings have minimal impact on how people respond to content, shows research

Trigger warnings that alert people to potentially sensitive content are increasingly popular, especially on college campuses, but research suggests that they have minimal impact on how people actually respond to content.

FDA clears Syneron Medical's elos Plus system

Syneron Medical Ltd., the global leader in medical aesthetic products and technology, announced today that it has received United States Food and Drug Administration (FDA) clearance for elos Plus, a next generation multi-platform system featuring the Company's proprietary elos technology.

New research looks at the role of geography in human adaptation

New research indicates that natural selection may shape the human genome much more slowly than previously thought. Other factors - the movements of humans within and among continents, the expansions and contractions of populations, and the vagaries of genetic chance - have heavily influenced the distribution of genetic variations in populations around the world.

Avanir Pharmaceuticals closes public offering of 20,930,000 shares of common stock

Avanir Pharmaceuticals, Inc. today announced the closing of its previously announced public offering of 20,930,000 shares of its common stock, including 2,730,000 shares sold pursuant to the underwriters' full exercise of their option to purchase additional shares, at a price to the public of $11.00 per share, before underwriting discounts.

Jonathan Woodson, MD - Surgery in East Boston, MA